Laboratory experiments evaluated delta-guaiene's antifungal effects on four skin fungi, suggesting natural bioactive potential.
Guaiene is a derivative compound produced as a byproduct in the production of patchouli alcohol from patchouli oil (Pogostemon cablin Benth.). This study aims to evaluate the antifungal activity of δ-guaiene extracted from patchouli oil originating from Subang against four types of skin pathogenic fungi: Aspergillus niger, Candida albicans, Microsporum gypseum, and Trichophyton mentagrophytes. The method used was a laboratory experiment, with the main parameters observed including Inhibition Zone Diameter (IZD), Minimum Inhibitory Concentration (MIC), and Minimum Fungicidal Concentration (MFC). The results showed that δ-guaiene inhibited the growth of C. albicans at a concentration of 40%, with an IZD of 0.15 mm. Against A. niger, the compound demonstrated an inhibition zone of 1.4 mm at a 20% concentration and had an MFC of 20%. For T. mentagrophytes, an IZD of 0.4 mm was observed, with both MIC and MFC at 20%. Activity against gypseum showed an IZD of 0.25 mm, with MIC and MFC also at 20%. These findings suggest that δ-guaiene from patchouli oil has potential as a candidate antifungal agent derived from local resources, supporting the development of natural bioactive compounds and sustainability.
No takes yet. Share an insight, caveat, or question.
Rahmawati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: